We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
1-Year Est. Return
41.24%
This Quarter
Est. Return
+25.64%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$69.2B
AUM Growth
+$1.61B
(+2.4%)
Cap. Flow
-$7.07B
Cap. Flow
% of AUM
-10.23%
Top 10 Holdings %
Top 10 Hldgs %
46.63%
Holding
2,045
New
180
Increased
582
Reduced
1,148
Closed
132
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$199M |
| 2 |
SNDK
Sandisk
SNDK
|
+$197M |
| 3 |
Genuine Parts
GPC
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$134M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$76.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQMM
ProShares GENIUS Money Market ETF
IQMM
|
+$876M |
| 2 |
NVIDIA
NVDA
|
+$678M |
| 3 |
Apple
AAPL
|
+$472M |
| 4 |
Microsoft
MSFT
|
+$341M |
| 5 |
Micron Technology
MU
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.21% |
| 2 | Miscellaneous | 27.25% |
| 3 | Industrials | 6.93% |
| 4 | Consumer Staples | 6.67% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Sana Biotechnology
SANA
$1.15B
| $116K | ﹤0.01% |
33,172
-3,084
| -9% | -$9.94K |
|
1752
CytomX Therapeutics
CTMX
$808M
| $114K | ﹤0.01% |
+30,448
| New | +$116K |
|
|
ADAM
1753
Adamas Trust
ADAM
$876M
| $114K | ﹤0.01% |
12,159
-1,071
| -8% | -$9.21K |
|
|
AGNT
1754
AGNT Inc
AGNT
$673M
| $114K | ﹤0.01% |
21,063
-10,055
| -32% | -$55.4K |
|
1755
Ironwood Pharmaceuticals
IRWD
$704M
| $113K | ﹤0.01% |
26,848
-3,626
| -12% | -$14K |
|
1756
Omeros
OMER
$1.37B
| $112K | ﹤0.01% |
11,818
-1,300
| -10% | -$15.5K |
|
1757
Lucid Motors
LCID
$1.84B
| $112K | ﹤0.01% |
+16,723
| New | +$108K |
|
1758
Coty
COTY
$2.58B
| $112K | ﹤0.01% |
51,711
+36,886
| +249% | +$79.6K |
|
1759
Candel Therapeutics
CADL
$978M
| $110K | ﹤0.01% |
+10,700
| New | +$80.8K |
|
1760
Burford Capital
BUR
$955M
| $110K | ﹤0.01% |
26,781
-2,391
| -8% | -$10.9K |
|
|
GOLD
1761
Gold.com Inc
GOLD
$1.34B
| $109K | ﹤0.01% |
+2,617
| New | +$113K |
|
1762
Certara
CERT
$1.21B
| $109K | ﹤0.01% |
+16,578
| New | +$93.4K |
|
1763
Aclaris Therapeutics
ACRS
$908M
| $106K | ﹤0.01% |
20,095
+1,399
| +7% | +$6.24K |
|
|
AVR
1764
Anteris Technologies
AVR
$881M
| $105K | ﹤0.01% |
10,700
-801
| -7% | -$6.09K |
|
1765
LegalZoom.com
LZ
$1.05B
| $105K | ﹤0.01% |
17,069
-2,241
| -12% | -$13.7K |
|
|
GTM
1766
ZoomInfo Technologies
GTM
$1.2B
| $103K | ﹤0.01% |
+35,272
| New | +$159K |
|
1767
Bloomin' Brands
BLMN
$838M
| $103K | ﹤0.01% |
11,290
-889
| -7% | -$6.47K |
|
1768
Sabre
SABR
$860M
| $103K | ﹤0.01% |
49,260
-8,680
| -15% | -$15.2K |
|
1769
Empire State Realty Trust
ESRT
$786M
| $102K | ﹤0.01% |
18,873
-1,422
| -7% | -$7.73K |
|
1770
Asana
ASAN
$2.02B
| $101K | ﹤0.01% |
14,414
+987
| +7% | +$6.63K |
|
1771
Tigo Energy
TYGO
$82.1M
| $99.4K | ﹤0.01% |
+42,649
| New | +$161K |
|
1772
Clarivate
CLVT
$1.32B
| $99K | ﹤0.01% |
+45,847
| New | +$112K |
|
1773
Altimmune
ALT
$665M
| $98.6K | ﹤0.01% |
32,427
+7,904
| +32% | +$23.6K |
|
1774
Tronox
TROX
$768M
| $98K | ﹤0.01% |
15,553
-1,777
| -10% | -$15.1K |
|
1775
Janus International
JBI
$694M
| $97K | ﹤0.01% |
17,483
-2,181
| -11% | -$11.4K |
|
Similar funds
ProShare Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, ProShare Advisors held 2,045 positions worth $69.2B, up 2.4% from $67.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
ProShare Advisors withdrew a net $7.07B in Q2 2026, closing 132 positions and reducing 1,148 holdings. Its most notable exit was Atlassian, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.
Against the trend, ProShare Advisors opened a new position in Honeywell Aerospace worth $76.5M.
- ProShare Advisors's largest Q2 2026 buy was Honeywell Aerospace: 346,243 shares worth $76.5M.
- ProShare Advisors added most to General Dynamics in Q2 2026, an estimated $199M increase.
- ProShare Advisors's biggest Q2 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $876M.
- ProShare Advisors fully exited Atlassian in Q2 2026, selling an estimated $14.7M.
- ProShare Advisors's ten largest holdings make up 47% of its $69.2B portfolio in Q2 2026.
- ProShare Advisors opened 180 new positions and closed 132 in Q2 2026.
- ProShare Advisors's portfolio value rose 2.4% quarter-over-quarter to $69.2B.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.